<SEC-DOCUMENT>0001144204-18-052523.txt : 20181107
<SEC-HEADER>0001144204-18-052523.hdr.sgml : 20181107
<ACCEPTANCE-DATETIME>20181004165901
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001144204-18-052523
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20181004

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Synthetic Biologics, Inc.
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133808303
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		(734) 332-7800

	MAIL ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADEONA PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIPEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20061214

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SHEFFIELD PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19970730
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 44px; width: 145px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;Synthetic Biologics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">9605 Medical Center Drive, Suite 270</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Rockville, Maryland 20850</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 4in">October 4, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>VIA EDGAR</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance<BR>
100 F Street, N.E.<BR>
Washington, D.C. 20549<BR>
Attention: Christine Westbrook</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><B><I>Re: &#9;Synthetic Biologics,
Inc.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><B><I>Registration Statement
on Form S-1</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in"><B><U>File No. 333-227400&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></B><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Ms. Westbrook:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Synthetic Biologics,
Inc. (the &#8220;<U>Company</U>&#8221;) hereby requests that the effective date of the Company&#8217;s Registration Statement on
Form&nbsp;S-1, as amended (File No.&nbsp;333-227400), be accelerated by the U.S. Securities and Exchange Commission to <B>Tuesday,
October 9, 2018 at 5:00 pm</B>, New York City Time, or as soon as reasonably practicable thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby
authorizes Leslie Marlow and/or Patrick Egan of Gracin &amp; Marlow, LLP to orally modify or withdraw this request for acceleration.
Please contact Ms. Marlow at (516) 496-2223 or (212) 907-6457, or Mr.&nbsp;Egan at (914) 557-5574 with any questions you may have
concerning this request, and please notify either of them when this request for acceleration has been granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><P STYLE="margin: 0pt 0">Synthetic Biologics, Inc.</P>


</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><B></B></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%"><U>/s/ Steven A. Shallcross</U>&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="vertical-align: top">Steven A. Shallcross</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD><P STYLE="margin: 0pt 0">Title:</P>


</TD>
    <TD STYLE="vertical-align: top"><P STYLE="margin: 0pt 0">Interim Chief Executive Officer and Chief Financial Officer</P>


</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ + "1 P$1  (1 0,1 ?_$ +T   (!! ,!
M      @)!P($!@H  0,% 0 ! P4!               %!@@)  (#! <!$
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MQ5 2' /:&MJKMRJ)D)7[V/JX]D:M+=O.U14G\,R]OMAK)%#"<Q1IOIU !':
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6]'FM>/XGVLHO_N_T:3W\CN@CX8__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
